The FINANCIAL -- Eli Lilly and Company announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, will undergo scheduled surgery for a dilated aorta on Monday, May 13, 2013.

The FINANCIAL -- Sedasys, a Division of Ethicon Endo-Surgery, Inc. (Ethicon), announced that the U.S. Food and Drug Administration (FDA) has granted PMA approval for the SEDASYS System, the first computer-assisted personalized sedation (CAPS) system.

The FINANCIAL -- KZPT uses the transparent and highly heat-resistant polycarbonate Apec FR 1892 from Bayer MaterialScience for the visors of its fire helmets.

The FINANCIAL -- GSK announced that the US Prescription Drug User Fee Act (PDUFA) goal date for trametinib, its MEK inhibitor, has been extended by 3 months to 3 September 2013.

The FINANCIAL -- GlaxoSmithKline plc announced the submission of a regulatory application in the US for the investigational once-daily medicine, umeclidinium bromide (UMEC), for patients with chronic obstructive pulmonary disease (COPD).